Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Starbucks Corporation (SBUX): Hedge Funds and Insiders Are Bullish, What Should You Do?

Page 1 of 2

Starbucks Corporation (NASDAQ:SBUX)Is Starbucks Corporation (NASDAQ:SBUX) a buy here? Hedge funds are in a bullish mood. The number of long hedge fund bets rose by 3 recently.

In the financial world, there are plenty of gauges shareholders can use to analyze their holdings. A pair of the most innovative are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best fund managers can beat the market by a healthy margin (see just how much).

Just as integral, optimistic insider trading sentiment is another way to parse down the world of equities. Obviously, there are lots of motivations for a corporate insider to get rid of shares of his or her company, but just one, very obvious reason why they would buy. Many academic studies have demonstrated the market-beating potential of this method if shareholders understand where to look (learn more here).

Keeping this in mind, we’re going to take a peek at the latest action encompassing Starbucks Corporation (NASDAQ:SBUX).

Hedge fund activity in Starbucks Corporation (NASDAQ:SBUX)

At Q1’s end, a total of 53 of the hedge funds we track were bullish in this stock, a change of 6% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of key hedge fund managers who were increasing their stakes meaningfully.

Of the funds we track, Scout Capital Management, managed by James Crichton and Adam Weiss, holds the most valuable position in Starbucks Corporation (NASDAQ:SBUX). Scout Capital Management has a $185.1 million position in the stock, comprising 2.4% of its 13F portfolio. The second largest stake is held by SAC Capital Advisors, managed by Steven Cohen, which held a $181.7 million position; 0.9% of its 13F portfolio is allocated to the company. Some other peers that hold long positions include Donald Chiboucis’s Columbus Circle Investors, John Lykouretzos’s Hoplite Capital Management and D. E. Shaw’s D E Shaw.

As one would reasonably expect, specific money managers were breaking ground themselves. Highline Capital Management, managed by Jacob Doft, initiated the largest call position in Starbucks Corporation (NASDAQ:SBUX). Highline Capital Management had 54.1 million invested in the company at the end of the quarter. David Stemerman’s Conatus Capital Management also made a $49.8 million investment in the stock during the quarter. The other funds with new positions in the stock are Mark Kingdon’s Kingdon Capital, Sanford J. Colen’s Apex Capital, and Jeffrey Jon Berney’s TriOaks Capital Management.

What do corporate executives and insiders think about Starbucks Corporation (NASDAQ:SBUX)?

Insider trading activity, especially when it’s bullish, is most useful when the company in question has experienced transactions within the past half-year. Over the last half-year time period, Starbucks Corporation (NASDAQ:SBUX) has seen 1 unique insiders purchasing, and 12 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Starbucks Corporation (NASDAQ:SBUX). These stocks are Panera Bread Co (NASDAQ:PNRA). All of these stocks are in the specialty eateries industry and their market caps resemble SBUX’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!